Thus, much like the increased FGF21 levels observed in obesity, it is not yet clear whether increased cardiac FGF21 reflects a compensatory response to combat FGF21 resistance, or whether it could be detrimental when expressed from the heart. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.